Avenue Therapeutics, Inc. Common Stock

ATXI

...

ATXI: Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, an oral small molecule for CNS diseases, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Show ATXI Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of ATXI by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by ATXI's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on ATXI's company Twitter account

WallStreetBets

Number of mentions of ATXI in WallStreetBets Daily Discussion

ATXI News

Recent insights relating to ATXI

CNBC Recommendations

Recent picks made for ATXI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATXI

Corporate Flights

Flights by private jets registered to ATXI